Koyfin Home > Directory > Health Care > Aduro Biotech > Total Debt / (EBITDA-CAPEX)

Aduro Biotech Total Debt / (EBITDA-CAPEX) Chart (ADRO)

Aduro Biotech annual/quarterly Total Debt / (EBITDA-CAPEX) from 2013 to 2020.
  • Aduro Biotech Total Debt / (EBITDA-CAPEX) for the quarter ending June 06, 2020 was $-1m a 22.66% decrease of 0m year over year
  • Aduro Biotech Total Debt / (EBITDA-CAPEX) for the last 12 months ending June 06, 2020 was $-1m a 14.68% decrease of 0m year over year
  • Aduro Biotech Annual Total Debt / (EBITDA-CAPEX) for 2019 was $0m a -101.87% increase of 0m from 2018
  • Aduro Biotech Annual Total Debt / (EBITDA-CAPEX) for 2013 was $-1m a 36.43% decrease of 0m from 2012
  • Aduro Biotech Annual Total Debt / (EBITDA-CAPEX) for 2012 was $-1m
Other Ratios Metrics:
  • Aduro Biotech Total Debt / Capital for the quarter ending September 09, 2014 was $4m
  • Aduro Biotech Other Liabilities for the quarter ending December 12, 2018 was $192m a 1.13% increase of 2m year over year
  • Aduro Biotech Total Debt / Equity for the quarter ending September 09, 2014 was $4m
View Chart On Koyfin

Quarterly ADRO Total Debt / (EBITDA-CAPEX) Data

06/2020$-1m
03/2020$-1m
12/2019$0m
09/2019$-1m
06/2019$-1m
03/2019$0m
09/2014$0m
03/2014$-1m
12/2013$-1m

Annual ADRO Total Debt / (EBITDA-CAPEX) Data

2019$0m
2013$-1m
2012$-1m